A comprehensive One Health investigation of erythromycin and quinupristin/dalfopristin resistant Enterococcus spp. in Iran
Journal of Water and Health · 2025
DOI: 10.2166/wh.2025.174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Water and Health, 2025. Verfasst von Fereshteh Hasanpour und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran. Hauptthemen laut MEDLINE: Erythromycin, Anti-Bacterial Agents, Virginiamycin, Enterococcus faecium. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Enterococci, flagged by the WHO as a rising cause of antibiotic-resistant infections, make surveillance crucial to control resistant strains. We investigated the resistance to linezolid, quinupristin/dalfopristin (Q/D), and erythromycin in Enterococcus faecalis (n = 251) and Enterococcus faecium (n = 434) isolates collected from patients, healthy carriers, hospitals, poultry, livestock, and municipal wastewater in Ardabil, Iran. The isolates were tested for resistance using phenotypic and genotypic methods. Although none of the isolates were resistant to linezolid, 24.9% of E. faecium isolates were resistant to Q/D, particularly those from patients and poultry slaughterhouse wastewater effluent (P < 0.05). The Q/D resistance genes msrC and ermB were detected in 76.85 and 20.37% of E. faecium isolates, respectively. Erythromycin resistance was common in E. faecalis (51.8%) and E. faecium (37.5%), with no significant difference between sources. However, isolates from patients and livestock wastewater had higher erythromycin MICs. Erythromycin resistance genes, such as ermB, ermC, ermTR, and ermA, were found in 80.7, 41.2, 26.5, and 19% of E. faecium and 80.3, 51.6, 22.4, and 25.8% of E. faecalis isolates, respectively. In conclusion, linezolid is a viable treatment for enterococcal infections in Ardabil, but widespread erythromycin- and Q/D-resistant enterococci pose a public health risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
- Zoonoses Research Center, Ardabil University of Medical Sciences, Ardabil, Iran; Department of Parasitology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
- Department of Community Medicine, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
- Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran; Zoonoses Research Center, Ardabil University of Medical Sciences, Ardabil, Iran E-mail: m.arzanlou@arums.ac.ir; arza…
ORCID-Profile: Mohsen Arzanlou
Zitieren
APA
Hasanpour, F., Khademi, F., Ghalehbin, B. M., Kheljan, M. N., Jannati, E., Iranpour, S., & Arzanlou, M. (2025). A comprehensive One Health investigation of erythromycin and quinupristin/dalfopristin resistant Enterococcus spp. in Iran. Journal of Water and Health. https://doi.org/10.2166/wh.2025.174
Vancouver
Hasanpour F, Khademi F, Ghalehbin BM, Kheljan MN, Jannati E, Iranpour S, et al. A comprehensive One Health investigation of erythromycin and quinupristin/dalfopristin resistant Enterococcus spp. in Iran. Journal of Water and Health. 2025. doi:10.2166/wh.2025.174
BibTeX
@article{Hasanpour2025,
author = {Hasanpour, Fereshteh and Khademi, Farzad and Ghalehbin, Behnam Mohammadi and Kheljan, Malek Namaki and Jannati, Elham and Iranpour, Sohrab and Arzanlou, Mohsen},
title = {A comprehensive One Health investigation of erythromycin and quinupristin/dalfopristin resistant Enterococcus spp. in Iran},
journal = {Journal of Water and Health},
year = {2025},
doi = {10.2166/wh.2025.174}
}
EUVIMED